Tolerance Bio
About:
Tolerance Bio is a biopharmaceutical company focused on manipulating immune tolerance via the thymus.
Website: https://www.tolerancebio.com
Top Investors: Criteria Bio Ventures, BioAdvance, Ben Franklin Technology Partners of Northeastern Pennsylvania, Columbus Venture Partners, Sessa Capital
Description:
Tolerance Bio is a biopharmaceutical company focused on manipulating immune tolerance via the thymus to address various immune-mediated diseases thymus.
Total Funding Amount:
$17.2M
Headquarters Location:
Founded Date:
2023-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2024-10-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai